Jean‐Claude Bystryn

4.9k total citations
122 papers, 3.6k citations indexed

About

Jean‐Claude Bystryn is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jean‐Claude Bystryn has authored 122 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Immunology, 44 papers in Molecular Biology and 38 papers in Pathology and Forensic Medicine. Recurrent topics in Jean‐Claude Bystryn's work include Immunotherapy and Immune Responses (45 papers), Autoimmune Bullous Skin Diseases (38 papers) and Monoclonal and Polyclonal Antibodies Research (31 papers). Jean‐Claude Bystryn is often cited by papers focused on Immunotherapy and Immune Responses (45 papers), Autoimmune Bullous Skin Diseases (38 papers) and Monoclonal and Polyclonal Antibodies Research (31 papers). Jean‐Claude Bystryn collaborates with scholars based in United States, Brazil and Australia. Jean‐Claude Bystryn's co-authors include Jennifer L. Rudolph, Gail K. Naughton, Desmond J. Tobin, Dean Johnston, Jonathan W. Uhr, Ruth Oratz, Daniel F. Roses, Sergei A. Grando, Jian Cui and Magdalena Eisinger and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Jean‐Claude Bystryn

122 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Claude Bystryn United States 37 1.4k 1.3k 887 865 848 122 3.6k
Jonathan W. Said United States 36 1.4k 1.0× 979 0.7× 232 0.3× 237 0.3× 475 0.6× 70 3.5k
Takeji Nishikawa Japan 33 2.6k 1.9× 353 0.3× 2.1k 2.4× 605 0.7× 1.8k 2.1× 164 4.5k
R Warnke United States 24 1.6k 1.1× 1.7k 1.3× 183 0.2× 133 0.2× 810 1.0× 32 4.1k
M. R. Parwaresch Germany 29 410 0.3× 1.5k 1.1× 502 0.6× 174 0.2× 296 0.3× 116 2.8k
L. Laroche France 34 2.2k 1.6× 1.8k 1.3× 426 0.5× 183 0.2× 445 0.5× 88 5.2k
S Poppema Netherlands 36 1.8k 1.3× 1.7k 1.3× 152 0.2× 177 0.2× 752 0.9× 93 4.6k
Sachiko Miyagawa Japan 26 548 0.4× 377 0.3× 674 0.8× 143 0.2× 248 0.3× 122 1.9k
Jonathan C. Poe United States 37 663 0.5× 4.2k 3.2× 460 0.5× 107 0.1× 435 0.5× 62 5.8k
Sara A. Michie United States 41 391 0.3× 2.3k 1.8× 184 0.2× 741 0.9× 124 0.1× 86 5.2k
Flavius Martin United States 27 496 0.4× 4.8k 3.7× 896 1.0× 111 0.1× 447 0.5× 39 6.5k

Countries citing papers authored by Jean‐Claude Bystryn

Since Specialization
Citations

This map shows the geographic impact of Jean‐Claude Bystryn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Claude Bystryn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Claude Bystryn more than expected).

Fields of papers citing papers by Jean‐Claude Bystryn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Claude Bystryn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Claude Bystryn. The network helps show where Jean‐Claude Bystryn may publish in the future.

Co-authorship network of co-authors of Jean‐Claude Bystryn

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Claude Bystryn. A scholar is included among the top collaborators of Jean‐Claude Bystryn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Claude Bystryn. Jean‐Claude Bystryn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Czernik, Annette, Siavash Toosi, Jean‐Claude Bystryn, & Sergei A. Grando. (2011). Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: An update. Autoimmunity. 45(1). 111–118. 38 indexed citations
2.
Toosi, Siavash & Jean‐Claude Bystryn. (2009). Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid. Medical Hypotheses. 74(4). 727–728. 19 indexed citations
3.
Cunha, Paulo Rowilson, et al.. (2006). Sensitivity of indirect immunofluorescence and ELISA in detecting intercellular antibodies in endemic pemphigus foliaceus (Fogo Selvagem). International Journal of Dermatology. 45(8). 914–918. 13 indexed citations
4.
Johnston, Dean, Sandra R. Reynolds, & Jean‐Claude Bystryn. (2005). Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice. Cancer Immunology Immunotherapy. 55(4). 412–419. 17 indexed citations
5.
Bystryn, Jean‐Claude & Jennifer L. Rudolph. (2005). Emerging melanoma vaccines. Expert Opinion on Emerging Drugs. 10(2). 393–402. 3 indexed citations
6.
Bystryn, Jean‐Claude, et al.. (2003). Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. Journal of the American Academy of Dermatology. 48(6). 976–977. 61 indexed citations
7.
McElwee, Kevin J., Dawnalyn Boggess, Thierry Olivry, et al.. (1998). Comparison of Alopecia areata in Human and Nonhuman Mammalian Species. Pathobiology. 66(2). 90–107. 59 indexed citations
8.
Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8 T cell responses to MAGE‐3 and Melan A/MART‐1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 3 indexed citations
9.
Reynolds, Sandra R., Ruth Oratz, Richard L. Shapiro, et al.. (1997). Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. International Journal of Cancer. 72(6). 972–976. 52 indexed citations
10.
Bystryn, Jean‐Claude, Richard L. Shapiro, M. C. Harris, Daniel F. Roses, & Ruth Oratz. (1996). Use of vaccines in treatment of malignant melanoma. Clinics in Dermatology. 14(4). 337–341. 3 indexed citations
11.
Cui, Jian, Yuko Arita, & Jean‐Claude Bystryn. (1995). Characterization of Vitiligo Antigens. Pigment Cell Research. 8(1). 53–59. 49 indexed citations
12.
Johnston, Dean, Soumaya El Rouby, & Jean‐Claude Bystryn. (1994). Identification of Melanoma Cell Surface Antigens Immunogenic in Mice. PubMed. 9(1). 29–38. 2 indexed citations
13.
Bystryn, Jean‐Claude, et al.. (1994). Identification of a Novel Basement Membrane Antigen (p84) Defined by Sera with Antibodies to Both the Epidermal and Dermal Side of Split Skin. Journal of Investigative Dermatology. 102(2). 236–240. 6 indexed citations
14.
Zhu, Xuejun, et al.. (1990). Molecular identification of major and minor bullous pemphigoid antigens. Journal of the American Academy of Dermatology. 23(5). 876–880. 7 indexed citations
15.
Bystryn, Jean‐Claude, Ruth Oratz, Matthew N. Harris, et al.. (1988). Immunogenicity of a polyvalent melanoma antigen vaccine in humans. Cancer. 61(6). 1065–1070. 54 indexed citations
16.
Bystryn, Jean‐Claude, et al.. (1982). Comparison of Cell-Surface Human Melanoma-Associated Antigens Identified by Rabbit and Murine Antibodies. Hybridoma. 1(4). 465–472. 27 indexed citations
17.
Wolf, Daniel & Jean‐Claude Bystryn. (1981). Alterations in Antigenic Properties of Normal Epidermis Adjacent to Basal Cell Carcinomas. Journal of Investigative Dermatology. 76(6). 442–444. 18 indexed citations
18.
Bystryn, Jean‐Claude, et al.. (1981). Release of surface macromolecules by human melanoma and normal cells.. PubMed. 41(3). 910–4. 16 indexed citations
19.
Bystryn, Jean‐Claude, Martin A. Nash, & Perry Robins. (1978). Epidermal Cytoplasmic Antigens: II. Concurrent Presence of Antigens of Different Specificities in Normal Human Skin. Journal of Investigative Dermatology. 71(2). 110–113. 24 indexed citations
20.
Bystryn, Jean‐Claude. (1977). Release of Cell-Surface Tumor-Associated Antigens by Viable Melanoma Cells From Humans2. JNCI Journal of the National Cancer Institute. 59(2). 325–328. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan W. Said Breakdown of academic impact, for papers by Takeji Nishikawa Breakdown of academic impact, for papers by R Warnke Breakdown of academic impact, for papers by M. R. Parwaresch Breakdown of academic impact, for papers by L. Laroche Breakdown of academic impact, for papers by S Poppema Breakdown of academic impact, for papers by Sachiko Miyagawa Breakdown of academic impact, for papers by Jonathan C. Poe Breakdown of academic impact, for papers by Sara A. Michie Breakdown of academic impact, for papers by Flavius Martin
Rankless by CCL
2026